Nancy Wysenski
Director/Board Member presso CYTOKINETICS, INCORPORATED
Patrimonio netto: 2 M $ in data 31/03/2024
Profilo
Nancy J.
Wysenski was the founder of EMD Pharmaceuticals, Inc. founded in 1999, where she held the position of President & Chief Executive Officer from 2001 to 2006.
Currently, she holds the position of Director at Alkermes, Inc. since 2013, Independent Director at Cytokinetics, Inc. since 2020, and President-Research Triangle Park Chapter at Healthcare Businesswomens Association.
In the past, she has worked as a Director at North American Scientific, Inc. and Reata Pharmaceuticals, Inc. She was also an Independent Director at Tetraphase Pharmaceuticals, Inc. from 2014 to 2020, Inovio Pharmaceuticals, Inc. from 2015 to 2017, and Dova Pharmaceuticals, Inc. from 2018 to 2019.
She held the position of Lead Independent Director at Alkermes Plc from 2022 to 2023.
She was the Chief Operating Officer at Indevus Pharmaceuticals, Inc. in 2009 and the Chief Commercial Officer & Executive VP at Vertex Pharmaceuticals, Inc. from 2011 to 2012.
She was also the Chief Operating Officer at Endo Health Solutions, Inc. from 2007 to 2009 and at Endo Pharmaceuticals, Inc. from 2007 to 2009.
She held the position of Senior Vice President-Operations at NetGenics, Inc. She was a Vice President-Field Sales at Astra Merck, Inc. from 1984 to 1998.
She is a Trustee at North Carolina Central University.
She holds an MBA from Baldwin-Wallace College and an undergraduate degree from Kent State University (Ohio).
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 07/07/2023 | 31 598 ( 0.02% ) | 855 358 $ | 31/03/2024 | |
| 29/02/2024 | 12 082 ( 0.01% ) | 847 069 $ | 31/03/2024 |
Posizioni attive di Nancy Wysenski
| Società | Posizione | Inizio |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Director/Board Member | 20/11/2020 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Director/Board Member | 01/05/2013 |
Healthcare Businesswomens Association
 Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Corporate Officer/Principal | - |
Precedenti posizioni note di Nancy Wysenski
| Società | Posizione | Fine |
|---|---|---|
| ALKERMES PLC | Director/Board Member | 08/12/2023 |
| PROVENTION BIO, INC. | Director/Board Member | 27/04/2023 |
| TETRAPHASE PHARMACEUTICALS, INC. | Director/Board Member | 28/07/2020 |
| DOVA PHARMACEUTICALS, INC. | Director/Board Member | 12/11/2019 |
| INOVIO PHARMACEUTICALS, INC. | Director/Board Member | 12/05/2017 |
Formazione di Nancy Wysenski
| Baldwin-Wallace College | Masters Business Admin |
| Kent State University (Ohio) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| CYTOKINETICS, INCORPORATED | Health Technology |
| INOVIO PHARMACEUTICALS, INC. | Health Technology |
| ALKERMES PLC | Health Technology |
| Aziende private | 13 |
|---|---|
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
Indevus Pharmaceuticals, Inc.
 Indevus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Indevus Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of products in the fields of urology, gynecology and infectious diseases. The company markets it's product SANCTURA for the treatment of overactive bladder and has compounds in clinical development including SANCTURA XR, NEBIDO, PRO 2000, IP 751, Pagoclone and Aminocandin. It focuses on the clinical development, regulatory review and commercialization of biopharmaceutical products. Indevus Pharmaceuticals was founded in 1988 and is headquartered in Lexington, MA. | Health Technology |
North American Scientific, Inc.
 North American Scientific, Inc. Electronic Equipment/InstrumentsElectronic Technology North American Scientific, Inc. manufactures and markets medical devices for the radiation oncology community. It offers intensity modulated and image guided radiation therapy products and services, as well as brachytherapy seeds used in the treatment of prostate cancer. The company also offers iodine-based and palladium-based implantable brachytherapy seeds for the treatment of prostate cancer. It provides a line of brachytherapy seeds for use in the treatment of ocular melanoma and other solid tumor applications. The company manufactures other radio isotopic products used in various medical, environmental, research and industrial applications. North American Scientific was incorporated in 1990 and is headquartered in Chatsworth, CA. | Electronic Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Endo Health Solutions, Inc. operates as holding company with interest in providing health care services. It offers pain management, pelvic health, urology, endocrinology and oncology services. The company was founded by Carol A. Ammon on November 18, 1997 and is headquartered in Malvern, PA. | Health Technology |
NetGenics, Inc.
 NetGenics, Inc. Packaged SoftwareTechnology Services NetGenics, Inc. develops software solutions for life science research. The firm provides bioinformatics solutions including the use of information technology by life science research companies to convert massive amounts of data into useful information that their scientists can then use in the development of new drugs, gene therapies, and agricultural products. The company was founded in 1996 and is headquartered in Cleveland, OH. | Technology Services |
Healthcare Businesswomens Association
Healthcare Businesswomens Association Miscellaneous Commercial ServicesCommercial Services Healthcare Businesswomens Association operates women healthcare associations. The company was founded by Diane Anderson, Peg Dougherty, Millicent Gryczka, Sheila Sinkking and Ruth Smith in 1977 and is headquartered in Fairfield, NJ. | Commercial Services |
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a private company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Health Technology |
EMD Pharmaceuticals, Inc.
 EMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Merck KGaA, EMD Pharmaceuticals, Inc. is a private company that manufactures pharmaceutical preparations. The company is based in Durham, NC. The company was founded by Nancy J. Wysenski. | Health Technology |
Dova Pharmaceuticals, Inc.
 Dova Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dova Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company, which engages in the acquisition, development and commercialization of drug candidates for rare diseases. It focuses on addressing thrombocytopenia, a disorder characterized by a low blood platelet count. Its drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist. The company was founded on March 24, 2016 and is headquartered in Durham, NC. | Health Technology |
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
- Borsa valori
- Insiders
- Nancy Wysenski
